These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6277749)

  • 21. [Effect of [Sar1, ile8] angiotensin II and SW 14,225 in renovascular hypertension--comparison between unilateral and bilateral renal artery stenosis (author's transl)].
    Ohta H; Ishida Y; Hara H; Yamamoto Y; Maekawa M; Takata M; Shimao M; Arai S; Takabatake T; Hattori N; Nomura G
    Nihon Jinzo Gakkai Shi; 1982 Jan; 24(1):79-88. PubMed ID: 7047821
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effects of angiotensin I converting enzyme inhibitor on renal function and serum potassium in renal and renovascular hypertension].
    Aoi W; Akahoshi M; Takahara A; Doi Y; Seto S; Kusano E; Suzuki S; Hashida K; Takagi H; Yoshioka M
    Nihon Jinzo Gakkai Shi; 1985 Nov; 27(11):1571-83. PubMed ID: 3007820
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical pharmacology and therapeutic applications of the new oral angiotensin converting enzyme inhibitor, captopril.
    Ferguson RK; Vlasses PH
    Am Heart J; 1981 May; 101(5):650-6. PubMed ID: 6261570
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of captopril on the level of arterial pressure and functional state of the kidney in symptomatic (renal) stable and malignant arterial hypertension].
    Lordkipanidze NL; Paleeva FM; Arabidze GG
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):39-41. PubMed ID: 6357226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of resistant hypertension with captopril in children with terminal insufficiency of renal function].
    Peco-Antić A; Popović-Rolović M; Popović D; Calić-Perisić N; Mancić J
    Srp Arh Celok Lek; 1983 Mar; 111(3):341-54. PubMed ID: 6362034
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of captopril on both hypertension and proteinuria. Report of a case of renovascular hypertension associated with nephrotic syndrome.
    Takeda R; Morimoto S; Uchida K; Kigoshi T; Sumitani T; Matsubara F
    Arch Intern Med; 1980 Nov; 140(11):1531-3. PubMed ID: 7002084
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapeutic effect of captopril in renal parenchymal hypertension].
    Chang X
    Zhonghua Nei Ke Za Zhi; 1983 Jul; 22(7):442-5. PubMed ID: 6357666
    [No Abstract]   [Full Text] [Related]  

  • 28. Beneficial haemodynamic effect of the angiotensin blocking agent captopril in patients with refractory heart failure.
    Lee CL; MacDonald GJ; Walsh WF
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():93-7. PubMed ID: 6291831
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of chronic congestive cardiac insufficiency with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
    Guerrera G; Melina D
    Minerva Cardioangiol; 1983 Mar; 31(3):93-100. PubMed ID: 6304571
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition of angiotensin-converting enzyme: therapeutic implications.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Isr J Med Sci; 1982 Oct; 18(10):981-5. PubMed ID: 6293997
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term converting enzyme inhibition versus surgical treatment in hypertensive patients with renovascular disease.
    Staessen J; Bulpitt CJ; Fagard R; Lijnen P; Amery A
    Neth J Med; 1984; 27(4):161-4. PubMed ID: 6330590
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect and tolerance of the angiotensin-converting enzyme inhibitor captopril (Tensobon)].
    Rahn KH; Stumpe KO
    MMW Munch Med Wochenschr; 1984 Feb; 126 Suppl 1():S5-14. PubMed ID: 6323979
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the angiotensin-converting enzyme inhibitor, captopril, on development of renal hypertension in rats.
    Fregly MJ; Lockley OE; Simpson CE
    Pharmacology; 1981; 22(5):277-85. PubMed ID: 7019935
    [No Abstract]   [Full Text] [Related]  

  • 35. Captopril for hypertension.
    Med Lett Drugs Ther; 1980 May; 22(9):39-40. PubMed ID: 6245345
    [No Abstract]   [Full Text] [Related]  

  • 36. [Remarkable hypotensive effect of converting enzyme inhibitor on a possible case of renin producing neoplasm].
    Sawamura A; Azuma J; Tanimoto T; Morita Y; Yamamura Y
    Nihon Rinsho; 1981 Mar; 39(3):689-93. PubMed ID: 7021921
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparison of blood pressure responses to captopril, an orally active converting enzyme inhibitor, in rats with various forms of experimental hypertension (author's transl)].
    Mikami H; Ogihara T; Kanda T; Higaki J; Naka T; Maruyama A; Hata T; Iwanaga K; Kumahara Y
    Nihon Naibunpi Gakkai Zasshi; 1980 Feb; 56(2):180-96. PubMed ID: 6245943
    [No Abstract]   [Full Text] [Related]  

  • 38. Captopril in hypertension after renal transplantation.
    Venkatachalam K; Kosanovich JM
    Clin Nephrol; 1983 May; 19(5):265-8. PubMed ID: 6342890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Captopril in renal artery stenoses and renal insufficiency].
    Kirchertz EJ; Scheler F
    Internist (Berl); 1982 Apr; 23(4):237-40. PubMed ID: 7045027
    [No Abstract]   [Full Text] [Related]  

  • 40. [Long term treatment of resistant hypertension with captopril (author's transl)].
    Guedon J; Chaignon M; Lucsko M; Cuche JL; Aubert P; Piete AM
    Nouv Presse Med; 1981 Apr; 10(19):1565-9. PubMed ID: 7025846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.